April 1, 2023
  • Facebook
  • Twitter
  • LinkedIn

BiomolBiomed Viewpoints

Science in plain words

  • Home
  • News
  • About
    • BiomolBiomed Viewpoints
    • BiomolBiomed Journal
  • Journal Website
  • Reviews
  • pathology
  • microbiology
  • immunology
  • translational medicine
  • genetics
  • biochemistry
  • anatomy
  • molecular biology
  • clinical medicine
  • new methods
  • new medical entities
Latest posts
  • [ March 31, 2023 ] The Reviewer of the Month for April 2023: Ioana-Miruna Balmus, PhD Reviewer of the month
  • [ March 2, 2023 ] The Reviewer of the Month for March 2023: Ognjen Barcot Reviewer of the month
  • [ February 14, 2023 ] BiomolBiomed’s Countdown: Most Cited and Most Shared Paper Awards 2023 News
  • [ February 13, 2023 ] Hematopathology Course on Lymphoma, March 31-April 1 (Izmir, Turkey) News
  • [ February 3, 2023 ] The Reviewer of the Month for February 2023: Dr. Chris Labaki Reviewer of the month
Homeimmunotherapy

immunotherapy

New biomarkers for predicting low-grade glioma prognosis
Author Summary

New biomarkers for predicting low-grade glioma prognosis

December 5, 2022 0

Low-grade glioma (LGG) belongs to a large class of gliomas, tumors that occur in the brain and spinal cord, with great intrinsic heterogeneity. In recent years, in-depth studies of the tumor microenvironment have made a […]

Colorectal cancer patients may benefit from dual-drug immunotherapy
Author Summary

Colorectal cancer patients may benefit from dual-drug immunotherapy

November 28, 2022 0

Colorectal cancer is the 3rd most common cancer worldwide. Immunotherapy has been shown to be therapeutically effective in patients with colorectal cancer who have significant levels of microsatellite instability (regions of repeated DNA that change […]

Microsatellite instability status predicts response to anti-PD-L1 therapy regardless the histotype
News

Microsatellite instability status predicts response to anti-PD-L1 therapy regardless the histotype

July 22, 2017 0

Le et al. recently reported (Science 10.1126/science.aan6733 (2017); (ClinicalTrials.gov number, NCT01876511) on the success of immune checkpoint blockade with anti-PD-1 antibodies in the patients whose cancers exhibited microsatellite instability-high (MSI-H) status. The study included 12 […]

Recent advances in cancer immunotherapy based in immune checkpoint inhibitors
News

Recent advances in cancer immunotherapy based in immune checkpoint inhibitors

June 9, 2017 0

Targeted therapy based on the immune checkpoint inhibitors (Anti-PD1/PD-L1) has revolutionized cancer treatment and outcome of several solid and hematologic malignancies, including non-small cell lung carcinoma (NSCLC), metastatic renal cell carcinoma, metastatic malignant melanoma, advanced/metastatic […]

VIDEO SUMMARIES

BiomolBiomed journal metrics

  • Impact Factor 2021 (JCR®): 3.76
  • CiteScore 2020 (Scopus): 5.2
  • Google Scholar Citations
  • Dimensions metrics

See more here…

BiomolBiomed Newsletters

Subscribe to receive the latest content and news from Biomolecules and Biomedicine. Choose from our sections or themes of your interest.

Categories

  • Author Summary
  • News
  • Opinion
  • Reviewer of the month
  • Topics
  • Video Summary

Archives

TELL US

What matters the most when choosing the journal to submit your article?
Vote
Follow us on Facebook

Copyright (c) 2021 Association of Basic Medical Sciences of FBIH

 

Loading Comments...